SNS Financial Group, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1557485 MINNEAPOLIS, MN

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$12,312,420

New position

Shares Held

19,746

first reported quarter

Ownership

0.019%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#266

of 1,322 holders

Holding Since

Jun 2026

1 quarter on record

Healthcare · as of Jun 30, 2026

SNS Financial Group, LLC holds $12,656,075 across 3 Biotechnology names. REGN ranks #1 (97.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	19,746	$12,312,420
2	VRTX	Vertex Pharmaceuticals Inc / Ma	607	$301,515
3	ATNM	Actinium Pharmaceuticals, Inc.	43,000	$42,140

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,312,420	19,746	—	Shares	Sole	2026-08-11
No filing history on record for this holder in this stock.